Literature DB >> 30624325

Editorial: Importance of Validating the Scores We Use to Assess Patients with Musculoskeletal Tumors.

Seth S Leopold1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30624325      PMCID： PMC6437386          DOI： 10.1097/CORR.0000000000000631

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  14 in total

1.  Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures.

Authors:  Guillaume Lonjon; Isabelle Boutron; Ludovic Trinquart; Nizar Ahmad; Florence Aim; Rémy Nizard; Philippe Ravaud
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

2.  Editorial: The Minimum Clinically Important Difference-The Least We Can Do.

Authors:  Seth S Leopold; Raphaël Porcher
Journal:  Clin Orthop Relat Res       Date:  2017-01-25       Impact factor: 4.176

Review 3.  Potential Pitfalls of Reporting and Bias in Observational Studies With Propensity Score Analysis Assessing a Surgical Procedure: A Methodological Systematic Review.

Authors:  Guillaume Lonjon; Raphael Porcher; Patrick Ergina; Mathilde Fouet; Isabelle Boutron
Journal:  Ann Surg       Date:  2017-05       Impact factor: 12.969

4.  Cross-cultural adaptation and validation of the Japanese version of the Toronto Extremity Salvage Score (TESS) for patients with malignant musculoskeletal tumors in the upper extremities.

Authors:  Toru Akiyama; Kosuke Uehara; Koichi Ogura; Yusuke Shinoda; Shintaro Iwata; Kazuo Saita; Yoshikazu Tanzawa; Fumihiko Nakatani; Tsukasa Yonemoto; Hirotaka Kawano; Aileen M Davis; Akira Kawai
Journal:  J Orthop Sci       Date:  2016-10-12       Impact factor: 1.601

5.  Cross-cultural adaptation and validation of the Korean Toronto Extremity Salvage Score for extremity sarcoma.

Authors:  Han-Soo Kim; JiYeon Yun; Seungcheol Kang; Ilkyu Han
Journal:  J Surg Oncol       Date:  2015-06-12       Impact factor: 3.454

6.  Reliability and Validity of the Musculoskeletal Tumor Society Scoring System for the Upper Extremity in Japanese Patients.

Authors:  Kosuke Uehara; Koichi Ogura; Toru Akiyama; Yusuke Shinoda; Shintaro Iwata; Eisuke Kobayashi; Yoshikazu Tanzawa; Tsukasa Yonemoto; Hirotaka Kawano; Akira Kawai
Journal:  Clin Orthop Relat Res       Date:  2017-05-30       Impact factor: 4.176

7.  Validation of a functional evaluation system in patients with musculoskeletal tumors.

Authors:  Sang Hoon Lee; Dong Joon Kim; Joo Han Oh; Hyuk Soo Han; Kwang Hyun Yoo; Han Soo Kim
Journal:  Clin Orthop Relat Res       Date:  2003-06       Impact factor: 4.176

8.  Cross-cultural adaptation and validation of the Japanese version of the Toronto Extremity Salvage Score (TESS) for patients with malignant musculoskeletal tumors in the lower extremities.

Authors:  Koichi Ogura; Kosuke Uehara; Toru Akiyama; Shintaro Iwata; Yusuke Shinoda; Eisuke Kobayashi; Kazuo Saita; Tsukasa Yonemoto; Hirotaka Kawano; Hirokazu Chuman; Aileen M Davis; Akira Kawai
Journal:  J Orthop Sci       Date:  2015-08-26       Impact factor: 1.601

9.  Validation of the Brazilian version of the musculoskeletal tumor society rating scale for lower extremity bone sarcoma.

Authors:  Daniel Cesar Seguel Rebolledo; João Ricardo Nickenig Vissoci; Ricardo Pietrobon; Olavo Pires de Camargo; Andre Mathias Baptista
Journal:  Clin Orthop Relat Res       Date:  2013-08-06       Impact factor: 4.176

10.  A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.

Authors:  W F Enneking; W Dunham; M C Gebhardt; M Malawar; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1993-01       Impact factor: 4.176
View more
  3 in total

1.  The critical difference in the DASH (Disabilities of the Arm, Shoulder, and Hand) outcome measure after essential upper extremity tumor surgery.

Authors:  Koichi Ogura; Mohamed A Yakoub; Alexander B Christ; Tomohiro Fujiwara; Zarko Nikolic; Patrick J Boland; Edward A Athanasian; John H Healey
Journal:  J Shoulder Elbow Surg       Date:  2021-01-20       Impact factor: 3.507

2.  What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?

Authors:  Koichi Ogura; Mohamed A Yakoub; Alexander B Christ; Tomohiro Fujiwara; Zarko Nikolic; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2020-09       Impact factor: 4.755

3.  CORR Insights®: What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?

Authors:  Stein J Janssen
Journal:  Clin Orthop Relat Res       Date:  2020-09       Impact factor: 4.755
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.